INTERNATIONAL PATENT: GENZYME CORPORATION FILES APPLICATION FOR "TREATMENT OF HEMOPHILIA A WITH FITUSIRAN"

GENEVA, March 26 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/US2024/046873) for "TREATMENT OF HEMOPHILIA A WITH FITUSIRAN" on Sep 16, 2024. With publication no. WO/2025/059635, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERSSON, Shauna (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), CANO, Viridiana (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), CHHABRA, Ekta Seth (c/o Sanofi, Patent Department4...